MGFA has partnered with Bionews to feature the “Myasthenia Gravis News” feed on our MGFA website. We are excited to offer the MG Community this insightful and informative news feed that covers many aspects of living with myasthenia – from research and study results to managing MG, helpful tips, and important news from across the MG World.
Myasthenia Gravis News is a digital platform intended to provide the myasthenia gravis (MG) community with the most recent news and information on MG, as well as first-hand community perspectives from patient and caregiver columnists. All articles on Myasthenia Gravis News are original content produced by in-house writers and editors. Occasionally, BioNews seeks the opinion of outside experts for interviews and Q&As.
Myasthenia Gravis News – The Web’s Daily Resource for Myasthenia Gravis News
- How I’m able to continue teaching while living with myasthenia gravis
by Sarah Bendiff on February 26, 2026 at 3:00 pmAny job comes with pros and cons, and working while living with a chronic disease highlights the cons in bright colors. While I often talk about my digital career, I never thought to share one of the most physically challenging jobs I’ve had with myasthenia gravis (MG): teaching. At first glance, teaching might seem harmless. The post How I’m able to continue teaching while living with myasthenia gravis appeared first on Myasthenia Gravis News.
- Benefits of statins may outweigh risks for many living with MG
by Margarida Maia, PhD on February 26, 2026 at 1:00 pmWhile certain medications are typically avoided in myasthenia gravis (MG), a large-scale study from France suggests that cholesterol-lowering statins may actually reduce the overall risk of death in these patients. The research indicates that although statins can slightly increase the short-term chance of a severe symptom flare-up, their long-term cardiovascular benefits appear to outweigh the The post Benefits of statins may outweigh risks for many living with MG appeared first on Myasthenia Gravis News.
- Problems with disturbed sleep affect 2 in 3 people with stable MG: Study
by Andrea Lobo on February 25, 2026 at 3:30 pmMore than two-thirds of people with clinically stable myasthenia gravis (MG) have problems with disturbed sleep, with resulting negative effects on their quality of life, a survey study of hundreds of MG patients in China has found. Further, those with sleep problems were significantly more likely to have obstructive sleep apnea, a serious sleep disorder The post Problems with disturbed sleep affect 2 in 3 people with stable MG: Study appeared first on Myasthenia Gravis News.
- Distinct immune profile found in treatment-resistant myasthenia gravis
by Steve Bryson, PhD on February 24, 2026 at 1:00 pmResearchers in the U.K. have identified a distinct immune profile in adults with myasthenia gravis (MG) whose disease does not respond to standard therapies. “Understanding these immune differences brings us closer to predicting how patients will respond to therapy and to developing more targeted, personalised treatment approaches,” Madhvi Menon, PhD, the study’s senior author at The post Distinct immune profile found in treatment-resistant myasthenia gravis appeared first on Myasthenia Gravis News.
- Loving someone with MG: What partners wish they knew sooner
by Shawna Barnes on February 23, 2026 at 3:00 pmLoving someone with myasthenia gravis (MG) isn’t a rom-com, inspirational-poster kind of love. It’s the sleeves-rolled-up, “we’re figuring this out in real time,” “in sickness and never mind” kind of love. MG doesn’t just change the person who carries it; it reshapes the entire relationship. I’ve lived with this disease long enough to witness how The post Loving someone with MG: What partners wish they knew sooner appeared first on Myasthenia Gravis News.
** MGFA Disclaimer – Please read
Myasthenia Gravis Foundation of America (MGFA) and Bionews, Inc. (specifically Myasthenia Gravis News) have entered into a limited agreement that allows for the MGFA to post a link to Myasthenia Gravis News on the myasthenia.org website. Myasthenia Gravis News is a digital platform intended to provide the myasthenia gravis (MG) community with the most recent news and information on MG, as well as first-hand community perspectives from patient and caregiver columnists. All articles on Myasthenia Gravis News are original content produced by in-house writers and editors. Occasionally, Bionews seeks the opinion of outside experts for interviews and Q&As.
The publishing team at Myasthenia Gravis News is made up of science writers and editors, most of whom have PhDs in the life sciences; veteran journalists; and columnists who are members of the MG community. Together, they attempt to ensure that all content published on Myasthenia Gravis News is relevant, accurate, informative, relatable, and easy to understand.
Each piece of content is carefully selected and written by Bionews writers with the MG community in mind. Sources for news stories and resource pages include peer-reviewed studies, press releases, announcements, interviews, webinars, and conference sessions, among others. All articles go through a stringent fact-checking and editing procedure as part of Bionews’ process to ensure they are accurate, objective, comprehensive, and well-explained.
Columns are written by MG patients and caregivers who provide an intimate look at what it’s like to live with the disease. While columns are largely opinion and perspective pieces, each one still goes through a comprehensive editing and fact-checking process by Bionews editors to ensure clarity, accuracy, and fairness.
Myasthenia Gravis News’ site is strictly a news and information website about the disease. It DOES NOT provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a licensed physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. The information provided is for educational purposes only and does not substitute for professional medical advice.
The content reflects the unique experiences of the authors and is not necessarily the opinion, views, or recommendations of the MGFA. Medical advisors and clinicians associated with or partnering with the MGFA do not peer review articles and information posted on the Myasthenia Gravis News platform or website. MGFA should not be liable for any information, opinions, articles, advice, guidance, or details posted on the Myasthenia Gravis News site. MGFA has posted this platform as a service to the MG community. Please consult with your doctor and healthcare professionals for specific recommendations and advice pertaining to your healthcare/treatment.